Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 57, Issue 7

Issues

Accuracy of determination of the glomerular filtration marker iohexol by European laboratories as monitored by external quality assessment

Gunnar Nordin / Sara Ekvall / Carolina Kristoffersson / Ann-Sofie Jonsson / Sten-Erik Bäck / Niclas Rollborn
  • Department of Medical Sciences, Section of Clinical Chemistry, Uppsala University, Uppsala, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Anders Larsson
  • Corresponding author
  • Department of Medical Sciences, Section of Clinical Chemistry, Uppsala University, Akademiska Sjukhuset, Entrance 61, 3rd Floor, Uppsala SE-75185, Sweden, Phone: +46 18 611 00 00, Fax: +46 18 611 37 03
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-05-10 | DOI: https://doi.org/10.1515/cclm-2018-1175

Abstract

Background

Glomerular filtration is the most important kidney function. The most accurate glomerular filtration rate (GFR) estimates are based on the clearance of exogenous filtration markers. Of these, iohexol is the only exogenous marker that is included in an external quality assessment (EQA) scheme. The aim of the present study was to evaluate the performance of the European laboratories participating in Equalis’ EQA scheme for iohexol.

Methods

Weighed amounts of iohexol (Omnipaque) were added to plasma samples and distributed to laboratories participating in the EQA scheme for iohexol. All laboratories performed the assays in a blinded fashion.

Results

The number of participating laboratories varied between 27 and 34 during the study period. Iohexol was determined by HPLC in 77% of the laboratories and by UPLC/MS/MS methods in 15% of the laboratories. The mean interlaboratory coefficient of variation was 4.7% for the HPLC methods and 6.4% for the UPLC/MS/MS methods. The mean bias between calculated and measured iohexol values was –1.3 mg/L (95% confidence interval ±0.3) during the first part of the study period and 0.1 mg/L (±0.3) during the later part.

Conclusions

The low interlaboratory variation demonstrates that iohexol can be measured reliably by many laboratories and supports the use of iohexol as a GFR marker when there is a need for high quality GFR measurements.

Keywords: external quality assessment scheme; GFR; glomerular filtration rate; iohexol

References

  • 1.

    Filler G, Yasin A, Medeiros M. Methods of assessing renal function. Pediatr Nephrol 2014;29:183–92.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 2.

    Soveri I, Berg UB, Bjork J, Elinder CG, Grubb A, Mejare I, et al. Measuring GFR: a systematic review. Am J Kidney Dis 2014;64:411–24.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 3.

    Frennby B, Sterner G. Contrast media as markers of GFR. Eur Radiol 2002;12:475–84.PubMedCrossrefGoogle Scholar

  • 4.

    Delanaye P, Melsom T, Ebert N, Back SE, Mariat C, Cavalier E, et al. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: why to measure glomerular filtration rate with iohexol? Clin Kidney J 2016;9:700–4.Web of ScienceCrossrefPubMedGoogle Scholar

  • 5.

    Delanaye P, Ebert N, Melsom T, Gaspari F, Mariat C, Cavalier E, et al. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: how to measure glomerular filtration rate with iohexol? Clin Kidney J 2016;9:682–99.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 6.

    Erley CM, Bader BD, Berger ED, Tuncel N, Winkler S, Tepe G, et al. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 2004;19:2526–31.PubMedCrossrefGoogle Scholar

  • 7.

    Ye T, Xu B, Wang Z, Zhang TY, Hu CY, Lin L, et al. Comparison of iodinated trihalomethanes formation during aqueous chlor(am)ination of different iodinated X-ray contrast media compounds in the presence of natural organic matter. Water Res 2014;66:390–8.CrossrefWeb of SciencePubMedGoogle Scholar

  • 8.

    Crosier AE, Henghali JN, Howard J, Pukazhenthi BS, Terrell KA, Marker LL, et al. Improved quality of cryopreserved cheetah (Acinonyx jubatus) spermatozoa after centrifugation through Accudenz. J Androl 2009;30:298–308.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 9.

    Gaspari F, Thakar S, Carrara F, Perna A, Trillini M, Aparicio MC, et al. Safety of Iohexol administration to measure glomerular filtration rate in different patient populations: a 25-year experience. Nephron 2018;140:1–8.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 10.

    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1–266.PubMedGoogle Scholar

  • 11.

    Delanaye P, Jouret F, Le GC, Cavalier E. Concordance between iothalamate and iohexol plasma clearance. Am J Kidney Dis 2016;68:329–30.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 12.

    Krutzen E, Back SE, Nilsson-Ehle I, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med 1984;104:955–61.PubMedGoogle Scholar

  • 13.

    Perrone RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, Lawlor M, et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The modification of diet in renal disease study. Am J Kidney Dis 1990;16:224–35.CrossrefPubMedGoogle Scholar

  • 14.

    Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 1993;4:1159–71.Google Scholar

  • 15.

    Aarsand AK, Roraas T, Fernandez-Calle P, Ricos C, Diaz-Garzon J, Jonker N, et al. The biological variation data critical appraisal checklist: a standard for evaluating studies on biological variation. Clin Chem 2018;64:501–14.Web of SciencePubMedCrossrefGoogle Scholar

About the article

Received: 2018-11-01

Accepted: 2019-01-17

Published Online: 2019-05-10

Published in Print: 2019-06-26


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: The Uppsala University Hospital Research Fund, Sweden supported this study.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 7, Pages 1006–1011, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-1175.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in